Alpha-Carotene: A Comprehensive Reference
1. Identity: Chemical Names, Structure, and Classification
Alpha-carotene (α-carotene) is a form of carotene with a β-ionone ring at one end and an α-ionone ring at the opposite end. This asymmetric ring arrangement is a defining structural feature that distinguishes it from its more abundant congener, beta-carotene. Alpha-carotene differs from β-carotene only by the position of the double bonds in the hydrocarbon ring.
α-Carotene is one of the C40 carotenes and a natural lipid-soluble terpene. The chemical structure is based on the unsaturated polyene chain skeleton, with an ε-ring and a β-ring on each side of the skeleton. Its molecular formula is C40H56, and it is registered in PubChem under CID 6419725 (as the (+)-enantiomer) and CID 4369188 (as all-trans-alpha-carotene).
Carotenes are hydrocarbons containing no oxygen and are therefore fat-soluble and insoluble in water, in contrast with other carotenoids, the xanthophylls, which contain oxygen and thus are less chemically hydrophobic.
It is the second most common form of carotene. α-Carotene, β-carotene, β-cryptoxanthin, lutein, zeaxanthin, and lycopene are the most common dietary carotenoids.
α-Carotene has a β-ionone ring at one end and an ε-ionone ring at the other, so it has half the retinol conversion capacity of β-carotene, which bears β-ionone rings at both ends and can be cleaved symmetrically to yield two molecules of retinol.
Common synonyms and names include:
- α-Carotene; alpha-carotene
- β,ε-Carotene (systematic)
- (6R)-4,5-Didehydro-5,6-dihydro-β,β-carotene (IUPAC)
- CAS number: 7488-99-5
2. Natural Sources and Occurrence
α-Carotene is widely found in dietary fruits and vegetables, and the concentration depends on the plant species. Processing methods and storage conditions used in the food and medical industries can alter the concentration of α-carotene in raw materials.
The major dietary sources of α-carotene are carrots, winter squash, and pumpkin. The distribution of carotenoids in human plasma seems to reflect the composition of carotenoids ingested via the diet, especially from fruit and vegetables.
Yellow-orange vegetables rich in alpha-carotene include carrots (the main source for U.S. adults), sweet potatoes, pumpkin, and winter squash. Dark-green vegetables rich in alpha-carotene include broccoli, green beans, green peas, spinach, turnip greens, collards, leaf lettuce, and avocado.
α-Carotene is especially high in orange carrots and some pumpkins; high serum concentrations are associated with carrot and pumpkin intake.
It is also present in Cryptophyta and Chlorophyceae (algal classes), making it available from both terrestrial and aquatic plant sources.
In American and Chinese adults, the mean concentration of serum α-carotene has been reported at 4.71 μg/dL, with 4.22 μg/dL among men and 5.31 μg/dL among women.
3. Historical and Traditional Context
Alpha-carotene does not have an independent traditional medicinal history distinct from the broader history of carotene-rich foods, because it was not chemically identified until the twentieth century. However, the broader discovery of carotene itself has a documented history.
The discovery of carotene from carrot juice is credited to Heinrich Wilhelm Ferdinand Wackenroder, published in 1831, during a search for antihelminthics. He obtained it in small ruby-red flakes soluble in ether, which when dissolved in fats gave "a beautiful yellow colour."
In the early part of the nineteenth century, carotenoids were found in paprika (1817), saffron (1818), annatto (1825), carrots (1831), and autumn leaves (1837).
About 100 years after its initial discovery, Kuhn found in 1931 that the naturally occurring carotene from carrots is composed of three isomers which he named α-carotene, β-carotene, and γ-carotene. In untreated carrot carotene, they are contained at proportions of about 15%, 85%, and 0.1%, respectively.
Ever since the first carotenoid syntheses by P. Karrer and H. H. Inhoffen (1950), a rapid development commenced in the field of commercial syntheses of carotenoids.
Historically, carrots, pumpkins, and related orange and yellow vegetables were consumed across many cultures for their nutritional properties — particularly their association with supporting vision and overall vitality — long before the specific role of individual carotenoids was understood. However, no traditional medicine system historically isolated or specifically attributed health effects to alpha-carotene as a distinct compound separate from the whole food or mixed carotenoid context. Scientific investigation of alpha-carotene as a distinct entity only became possible after Kuhn's 1931 characterization of the carotene isomers, and systematic epidemiological research on it began in earnest in the latter decades of the twentieth century.
4. Key Constituents, Biosynthesis, and Mechanisms of Action
4.1 Biosynthetic Origin
Carotenoids are synthesized in the plastids of plants' photosynthetic apparatus and serve as vital pigments for photosynthesis, cellular repairs, and protection. The backbone is made from eight isoprene units connected head-to-tail, except for the central unit, which has a reverse connection. These tetraterpenes are produced via the dimerization of geranylgeranyl pyrophosphate in plants, algae, bacteria, fungi, aphids, and spider mites.
Lycopene may have one of two different fates in the biosynthetic pathway: through the action of lycopene epsilon cyclase it may become alpha-carotene, or it may be transformed into beta-carotene by lycopene cyclase. This single enzyme difference — the cyclization of one end of the lycopene molecule by epsilon-cyclase rather than beta-cyclase — accounts for the structural distinction between α- and β-carotene, specifically the presence of the ε-ionone ring rather than a second β-ionone ring.
4.2 Provitamin A Activity
α-Carotene, β-carotene, and β-cryptoxanthin are provitamin A carotenoids, meaning they can be converted by the body to retinol. Currently, the only essential function of carotenoids recognized in humans is that of the provitamin A carotenoids — α-carotene, β-carotene, and β-cryptoxanthin — to serve as a source of vitamin A.
According to the NIH Office of Dietary Supplements, one mcg of retinol activity equivalent (RAE) is equivalent to 1 mcg retinol, 2 mcg supplemental beta-carotene, 12 mcg dietary beta-carotene, or 24 mcg of dietary alpha-carotene or beta-cryptoxanthin. This means that alpha-carotene has approximately half the provitamin A conversion efficiency of beta-carotene when consumed from dietary sources.
The conversion of provitamin A to retinol is dependent on the individual's status of vitamin A, and regulation mechanisms inhibit the conversion to vitamin A if retinol content in the human body exceeds the body's demand. This self-regulating conversion is an important safety feature distinguishing dietary carotenoids from preformed vitamin A.
In humans, conversion of β-carotene (and by extension α-carotene) into vitamin A takes place predominantly in the intestine and, to a lesser extent, in other tissues. The enzyme beta-carotene 15,15′-dioxygenase (BCO-1) cleaves β-carotene at the central double bond, creating an epoxide, as the primary step in conversion.
4.3 Antioxidant Mechanism
Like other carotenoids, alpha-carotene has antioxidant and possibly anti-carcinogenic properties, and may enhance immune function as well. The extended conjugated polyene chain of alpha-carotene enables it to quench singlet oxygen and neutralize free radicals through physical and chemical quenching mechanisms. This is consistent with the general mechanism of carotenoid antioxidant activity established across the carotenoid class.
While there is evidence that carotenes are antioxidants in vitro, their importance to health is not fully established in vivo. The one clear function of certain carotenoids firmly linked to a health outcome is the provitamin A activity of α-carotene, β-carotene, and β-cryptoxanthin, and their role in the prevention of vitamin A deficiency.
4.4 Anti-Proliferative Activity (Preclinical)
In laboratory studies, the proliferation of human malignant tumor cells was more effectively suppressed by α-carotene than by β-carotene. Additional functions including the ability to stimulate cell communication and immune system enhancement have also been reported for these carotenoids. These findings come from in vitro and animal models; direct human clinical trial evidence specifically for isolated alpha-carotene remains absent.
4.5 Absorption and Bioavailability
For dietary carotenoids to be absorbed intestinally, they must be released from the food matrix and incorporated into mixed micelles, which are mixtures of bile salts and several types of lipids. Dietary fat is required for this process. There is an increasing body of research showing that the use of retinol activity equivalents or retinol equivalents could lead to the underestimation of the contribution of α-carotene to dietary vitamin A supply, suggesting its bioavailability may be greater than standard conversion factors imply in certain food contexts.
5. Scientific Evidence by Area of Use
5.1 All-Cause and Cause-Specific Mortality
Study type and population: An assessment of the direct relationship between α-carotene concentrations and risk of death was conducted among 15,318 U.S. adults 20 years and older who participated in the Third National Health and Nutrition Examination Survey (NHANES III) Follow-up Study. Participants underwent a medical examination and provided blood samples between 1988 and 1994 and were followed through 2006 to determine whether and how they died.
Findings: Compared with participants with serum α-carotene concentrations of 0 to 1 μg/dL, those with higher serum levels had a lower risk of death from all causes (P < .001 for linear trend): the relative risk for death was 0.77 (95% CI, 0.68–0.87) among those with concentrations of 2 to 3 μg/dL, 0.73 (0.65–0.83) among those with concentrations of 4 to 5 μg/dL, 0.66 (0.55–0.79) among those with concentrations of 6 to 8 μg/dL, and 0.61 (0.51–0.73) among those with concentrations of 9 μg/dL or higher, after adjustment for potential confounding variables. Significant associations were also found between serum α-carotene concentrations and risk of death from CVD (P = .007), cancer (P = .02), and all other causes (P < .001).
Limitations acknowledged by researchers: As an observational study, the research was not designed to prove cause and effect. Clinical trials, which can correct for confounding factors, are often not as positive as such population studies — as was the case with previously encouraging findings about beta-carotene. The authors stated: "Our results, if replicated in other studies and populations, suggest a need for clinical research into the health benefits of serum alpha-carotene."
A 2018 meta-analysis found that both dietary and circulating α-carotene are associated with a lower risk of all-cause mortality.
Evidence strength: Moderate for an association between serum alpha-carotene and reduced mortality risk; the relationship is consistent and dose-dependent in large prospective observational data, but no randomized controlled trials of isolated alpha-carotene supplementation have been conducted to establish causation.
5.2 Cardiovascular Disease
In the NHANES III prospective study, serum alpha-carotene concentrations were inversely associated with risk of death from all causes, CVD, cancer, and all causes other than CVD and cancer. The inverse association was independent of demographic characteristics, lifestyle habits, and traditional health risk factors.
However, relatively few studies have directly examined the association between alpha-carotene concentrations and the risk of cancer or CVD, and findings from the limited number of studies on the association between serum or plasma alpha-carotene concentrations and risk of death have been inconsistent.
Evidence strength: Suggestive but preliminary. The epidemiological signal is consistent with that seen for total carotenoids, but alpha-carotene-specific clinical intervention data do not exist. Clinical trials to test isolated α-carotene's influences in humans have not been conducted to date.
5.3 Cancer Risk
Some, but not all, epidemiological studies observed that higher α-carotene intake was associated with lower risk of cardiovascular disease and cancer, whereas others did not. High dietary intake of α-carotene was associated with decreased prostate cancer risk in observational analyses.
A meta-analysis of 34 observational studies found that alpha-carotene is inversely associated with prostate cancer risk.
Although chemically similar to beta-carotene, alpha-carotene has been shown to be more effective at inhibiting certain cancer cells in preclinical (in vitro and animal) models.
Although studies suggest eating more fruits and vegetables is associated with lower risk of chronic diseases, randomized controlled trials have not shown any benefit for beta-carotene supplements. "Therefore, carotenoids other than beta-carotene may contribute to the reduction in disease risk, and their effects on risk of disease merit investigation," researchers have written.
Evidence strength: The cancer-related evidence for alpha-carotene specifically is primarily observational and partly from in vitro/animal models. Alpha-carotene is usually associated with ample amounts of β-carotene when found in fruits and vegetables, and singling out dietary α-carotene is difficult. No clinical trials of isolated alpha-carotene supplementation for cancer prevention have been completed in humans. Evidence is preliminary.
5.4 Cognitive Function
There is a dearth of evidence on the association between different forms of dietary carotenoids and cognition. One study leveraged the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) trial to examine the association between dietary intakes of carotenoids and global/domain-specific cognition using objective measurements of plasma concentrations.
A 2021 study showed that adults aged 65 to 84 with the highest serum levels of alpha-carotene had improved cognitive function compared to those with the lowest.
Evidence strength: Very preliminary; based on one analysis of a dietary intervention trial population. The large body of evidence from randomized intervention trials on blood concentrations of carotenoids and cognitive performance has been focused on β-carotene, the most common form of supplementation. No randomized controlled trials specifically investigating isolated alpha-carotene supplementation and cognition exist. This area warrants further investigation.
5.5 Muscle Strength and Sarcopenia Prevention
A cross-sectional study evaluating 1,172 individuals (627 men and 545 women) aged 50 to 85 years from NHANES 2001–2002 was performed. Carotenoids (including α-carotene, trans-β-carotene, cis-β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and trans-lycopene), vitamin E, and retinol were analyzed via high-performance liquid chromatography. Muscle strength was evaluated by the isokinetic knee extension test. Linear regression, adjusted for confounders including energy and protein intake, body mass index, sex, age, C-reactive protein, uric acid, race/ethnicity, marital status, income, educational level, physical activity, smoking, hypertension, arthritis, and diabetes, found that alpha-carotene levels (p-trend = 0.027) were positively associated with muscle strength.
Aging is associated with increased reactive oxygen species that can decrease muscle strength. Antioxidant substances could therefore be positively associated with muscle strength in older adults.
Evidence strength: Cross-sectional observational data only; causation cannot be established. The study is notable because alpha-carotene was the only antioxidant measured to show a statistically significant positive association with strength in this population, but the mechanism remains speculative and longitudinal or intervention data are lacking.
5.6 Vitamin A Adequacy
The one clear function of certain carotenoids that is firmly linked to a health outcome is the provitamin A activity of α-carotene, β-carotene, and β-cryptoxanthin, and their role in the prevention of vitamin A deficiency.
β-Carotene, α-carotene, and β-cryptoxanthin are greater contributors to vitamin A intake than retinol in the human diet for most people around the world. Their contribution depends on several factors, including bioavailability and capacity of conversion into retinol.
Evidence strength: Well-established for provitamin A function; this is the only role for alpha-carotene (and other provitamin A carotenoids) with a recognized essential function in humans according to the NIH and Linus Pauling Institute.
6. Body Systems and Health Areas Associated with Alpha-Carotene
- Visual system / vitamin A-dependent processes: α-Carotene is a provitamin A carotenoid, meaning it can be converted by the body to retinol, which supports vision, epithelial integrity, and immune function.
- Cardiovascular system: Epidemiological evidence links higher serum alpha-carotene to reduced cardiovascular disease mortality.
- Oncology (observational): Inverse associations with prostate cancer risk and overall cancer mortality have been reported in prospective cohort studies and meta-analyses of observational studies.
- Musculoskeletal system: Cross-sectional NHANES data associate higher serum alpha-carotene with greater muscle strength in older adults.
- Neurological / cognitive: Preliminary observational data from the MIND trial population suggest higher circulating alpha-carotene may be associated with better cognitive function in older adults.
- Antioxidant defense: Alpha-carotene has antioxidant and possibly anti-carcinogenic properties.
7. Dosage Forms and Doses Reported in Studies
Alpha-carotene is not currently available as a widely marketed isolated dietary supplement. In most research contexts, it is studied as a serum biomarker rather than as a supplemental ingredient. Clinical trials to test isolated α-carotene's influences in humans have not been conducted to date. Consequently, no established or consensus dosage for supplemental alpha-carotene exists.
In terms of dietary intake context, the NIH Office of Dietary Supplements states that one mcg RAE (retinol activity equivalent) is equivalent to 24 mcg of dietary alpha-carotene, providing a functional conversion framework for nutritional assessment. This means that to contribute a meaningful amount toward the adult RDA for vitamin A (900 mcg RAE for men and 700 mcg RAE for women), a substantially larger weight of alpha-carotene than beta-carotene would be required from dietary sources.
In the key NHANES III mortality study, the overall risk of death during the study was found to be reduced by up to 39% for those individuals with blood alpha-carotene levels of 9 micrograms per deciliter or higher, compared to those with the lowest levels (0–1 μg/dL). This was a serum concentration range achieved through habitual dietary intake, not through supplementation.
Alpha-carotene naturally accompanies beta-carotene in food sources such as carrots and pumpkin. In untreated carotene extracted from carrots, alpha-carotene constitutes approximately 15% of total carotene, with beta-carotene making up approximately 85%.
When alpha-carotene is present in mixed carotenoid supplement formulations (e.g., natural carrot oil extracts or mixed carotenoid supplements), it is present as a minor component. No published randomized controlled trials have administered isolated alpha-carotene at specific doses to human subjects for therapeutic purposes.
8. Safety Considerations and Interactions
8.1 Carotenodermia
No adverse effects other than carotenodermia have been reported from the consumption of β-carotene or other carotenoids in food. Carotenodermia is a harmless but clearly documented biological effect of high carotenoid intake. It is characterized by a yellowish discoloration of the skin that results from an elevation of carotene concentrations.
High doses of β-carotene supplements (≥30 mg/day) and the consumption of large amounts of carotene-rich food have resulted in a yellow discoloration of the skin known as carotenodermia, also called carotenemia. Carotenodermia is not associated with any underlying health problems and resolves when supplementation with β-carotene is discontinued or dietary carotene intake is reduced. The same principle applies to all dietary carotenes, including alpha-carotene.
8.2 No Vitamin A Toxicity Risk from Dietary Carotenoids
The conversion of provitamin A to retinol is dependent on the individual's vitamin A status, and regulation mechanisms inhibit the conversion to vitamin A if retinol content in the human body exceeds the body's demand. This regulatory mechanism means that alpha-carotene, like other provitamin A carotenoids, does not cause vitamin A toxicity (hypervitaminosis A) when consumed through food or in amounts achievable through typical dietary means.
Unlike vitamin A, high doses of β-carotene taken by pregnant women have not been associated with increased risk of birth defects.
8.3 Lung Cancer Risk: Caution in Smokers with High-Dose Carotene Supplementation
Although this safety signal specifically involves beta-carotene supplementation (not alpha-carotene), it is highly relevant as a class-level caution. Two large, randomized intervention trials investigated the effect of β-carotene supplementation on lung cancer. The Alpha Tocopherol, Beta Carotene Prevention trial (ATBC) included 29,000 participants who received 20 mg of β-carotene daily for 5–8 years. β-Carotene was given as water-soluble beadlets, resulting in much higher blood concentrations (up to ~10 times higher) compared with typical dietary intake. Both studies showed an increased lung cancer rate in the β-carotene groups (16% in the ATBC trial and 28% in the CARET study). The potential risk of lung cancer in smokers and other high-risk groups supplemented with high-dose β-carotene outweighs any possible benefits for chronic disease prevention. No equivalent trial data exist for isolated alpha-carotene supplementation in smokers.
8.4 Absorption-Related Interactions
Absorption of carotenes depends on the presence of bile and absorbable fat in the intestinal tract. Supplemental forms of carotene have markedly greater bioavailability than dietary carotene. Absorption is greatly decreased in patients with steatorrhea and chronic diarrhea. These principles apply to alpha-carotene as a fat-soluble compound.
Alpha-carotene is recognized among the lesser-studied carotenes that may confer some bioactivities; formal drug-nutrient interaction studies specific to alpha-carotene have not been published. Its interaction profile as a fat-soluble carotenoid is expected to parallel that of other carotenes: drugs that reduce fat absorption (such as orlistat) or bile production may reduce carotene absorption.
8.5 Absence of a Tolerable Upper Intake Level
No Tolerable Upper Intake Level (UL) has been set for alpha-carotene or other dietary carotenoids by the U.S. National Academies of Medicine, consistent with the finding that no adverse effects other than carotenodermia have been reported from the consumption of carotenoids in food. No isolated alpha-carotene supplement has been reviewed for a formal safety assessment by a regulatory body.
9. Research Gaps and Status of Evidence
A 2022 review in the journal of the Society of Chemical Industry summarized the major studies on chemical structure, source, extraction, detection, biosynthesis, processing effect, bioactivity, medicine, and biotechnology of α-carotene. Whether α-carotene supplementation or a diet rich in fruits and vegetables has a positive effect on the prevention of cancer, cardiovascular disease, and other diseases was identified as a central open question.
Clinical trials to test isolated α-carotene's influences in humans have not been conducted to date. This is probably because α-carotene is usually associated with ample amounts of β-carotene when found in fruits and vegetables, and singling out dietary α-carotene is difficult.
The scientific body of evidence for alpha-carotene remains significantly less developed than for beta-carotene or lycopene. All major health-related associations identified to date — including mortality, cardiovascular disease, cancer, cognitive function, and muscle strength — are based on observational or cross-sectional studies measuring serum alpha-carotene as a biomarker of fruit and vegetable consumption. These cannot establish causation and cannot be straightforwardly extrapolated to predict the effects of isolated supplementation.
References
- Li Q et al. "α-Carotene: a valuable carotenoid in biological and medical research." Journal of the Science of Food and Agriculture (2022). PubMed.
- Li C et al. "Serum α-Carotene Concentrations and Risk of Death Among US Adults: The Third National Health and Nutrition Examination Survey Follow-up Study." Archives of Internal Medicine (2011). PubMed.
- Li C et al. "Serum α-Carotene Concentrations and Risk of Death Among US Adults." Archives of Internal Medicine. Ovid/JAMA Network.
- Linus Pauling Institute, Oregon State University. "Carotenoids." Micronutrient Information Center (updated 2026).
- NIH Office of Dietary Supplements. "Vitamin A and Carotenoids — Health Professional Fact Sheet."
- PubChem. "Alpha-Carotene | C40H56 | CID 6419725." National Center for Biotechnology Information.
- PubChem. "all-trans-alpha-Carotene | C40H56 | CID 4369188." National Center for Biotechnology Information.
- Wikipedia. "α-Carotene."
- Wikipedia. "Carotene."
- Shardell MD et al. "Low serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: The Third National Health and Nutrition Examination Survey (NHANES III)." PMC (2011).
- Leermakers ETM et al. "Revisiting carotenoids as dietary antioxidants for human health and disease prevention." Food & Function, RSC Publishing (2023).
- Beydoun MA et al. "Higher circulating α-carotene was associated with better cognitive function: an evaluation among the MIND trial participants." Journal of Nutritional Science. PMC (2021).
- Bruno RR et al. "Serum α-Carotene, but Not Other Antioxidants, Is Positively Associated with Muscle Strength in Older Adults: NHANES 2001–2002." Antioxidants (Basel). PMC (2022).
- Bruno RR et al. "Serum α-Carotene, but Not Other Antioxidants, Is Positively Associated with Muscle Strength in Older Adults: NHANES 2001–2002." PubMed (2022).
- Meléndez-Martínez AJ et al. "Dietary β-Cryptoxanthin and α-Carotene Have Greater Apparent Bioavailability Than β-Carotene in Subjects from Countries with Different Dietary Patterns." PMC (2020).
- National Academies of Medicine. "β-Carotene and Other Carotenoids." Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. NCBI Bookshelf.
- ScienceDirect Topics. "Alpha-Carotene — an overview."
- Bohn T et al. "From carotenoid intake to carotenoid blood and tissue concentrations – implications for dietary intake recommendations." Nutrition Reviews (2021).
- Bruno RR et al. "Serum α-Carotene, but Not Other Antioxidants, Is Positively Associated with Muscle Strength in Older Adults: NHANES 2001–2002." MDPI Antioxidants (2022).
- Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases. PMC (2022).
- Carotenoids as Natural Functional Pigments. PMC (2020).
- Carotenoids for Antiaging: Nutraceutical, Pharmaceutical, and Cosmeceutical Applications. MDPI Pharmaceuticals (2025).
- Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids. ScienceDirect (2022).
Volver